Doctors Note Logo

Published on: 9/13/2026

Can taking metformin for years raise my MCV without lowering my hemoglobin?

Yes, years of metformin use can raise your MCV while hemoglobin stays normal, because the drug gradually reduces vitamin B12 absorption in the small intestine and macrocytosis often appears well before anemia does. Risk rises with higher doses, longer duration, and co-use of acid-suppressing drugs, and folate deficiency, thyroid disease, alcohol use, or liver problems can push MCV up at the same time. Because normal hemoglobin does not rule out a deficiency that may still cause nerve damage, testing B12 along with methylmalonic acid or homocysteine matters, and there are several important factors to consider before assuming metformin is the only cause. See below to understand more about which lab patterns point to metformin versus other explanations. If you have noticed tingling, numbness, fatigue, brain fog, or balance changes alongside a rising MCV, a free, instant, online symptom check can help you organize your symptoms, understand the most likely explanations, and decide how soon to bring this up with your prescriber.

Last reviewed for medical accuracy: 09/13/2026

answer background

Explanation

High MCV, Normal Hemoglobin: Can Long-Term Metformin Use Cause Macrocytosis?

Taking metformin for years is common in managing type 2 diabetes. You may have noticed a routine blood test showing a high mean corpuscular volume (MCV) even though your hemoglobin level remains normal. Is metformin to blame? Here’s what the evidence says, in clear, practical terms.

What MCV and Hemoglobin Tell You

  • MCV measures the average size of your red blood cells (RBCs). A normal MCV is roughly 80–100 femtoliters (fL). Values above 100 fL indicate macrocytosis (large RBCs).
  • Hemoglobin reflects how much oxygen-carrying protein is in your blood. Normal levels mean you aren’t anemic, even if your RBCs are larger.
  • High MCV with normal hemoglobin often appears before you develop anemia, making it an early warning sign.

How Metformin Can Lead to High MCV

  1. Vitamin B12 Malabsorption
    • Metformin interferes with calcium-dependent absorption of vitamin B12 in the small intestine.
    • After several years, up to 30% of people on metformin may develop low B12 levels.
  2. B12’s Role in Red Blood Cells
    • Vitamin B12 is key for DNA synthesis in RBC precursors. Without enough B12, cell division slows, producing fewer but larger RBCs (macrocytosis).
  3. Macrocytosis Before Anemia
    • Early B12 deficiency often raises MCV before hemoglobin drops. You may have high MCV yet still test within normal hemoglobin ranges.
    • If deficiency worsens, hemoglobin will eventually fall, causing macrocytic anemia with symptoms like fatigue, weakness, or pallor.

Key Research Findings

  • A 2010 review in Diabetes Care found that long-term metformin users had significantly lower B12 levels than non-users.
  • Clinical studies show macrocytosis can appear after 2–3 years on metformin, often without immediate hemoglobin changes.
  • Monitoring B12, methylmalonic acid (MMA) and homocysteine can detect early functional deficiency before anemia develops.

Other Causes of High MCV with Normal Hemoglobin
Metformin-induced B12 deficiency is common, but other factors can raise MCV:

  • Chronic alcohol use
  • Hypothyroidism
  • Liver disease
  • Certain medications (e.g., chemotherapy drugs, anticonvulsants)
  • Smoking
  • Early myelodysplastic syndromes
  • Recent blood loss or hemolysis (reticulocytosis temporarily raises MCV)

When to Be Concerned
High MCV on its own isn’t an emergency, but certain signs warrant prompt attention:

  • New or worsening numbness, tingling, burning in hands or feet
  • Cognitive changes: memory lapses or mood shifts
  • Unexplained fatigue, muscle weakness
  • Jaundice or abdominal pain (suggesting liver involvement)
    If you have any of these, it’s wise to seek medical advice without delay.

Practical Steps for Monitoring and Management

  1. Check Your Vitamin B12 Level
    • Ask your doctor for a serum B12 test, especially if you’ve taken metformin for over two years.
  2. Assess Functional Markers
    • Elevated MMA or homocysteine levels can confirm B12 deficiency even when serum B12 is borderline.
  3. Dietary Review
    • Incorporate B12-rich foods: meat, dairy, eggs, fortified cereals.
  4. Supplementation
    • Oral B12 (cyanocobalamin or methylcobalamin) often suffices. Typical doses range from 500–1,000 mcg daily.
    • In cases of severe deficiency or malabsorption, intramuscular B12 injections may be recommended.
  5. Repeat Testing
    • Recheck MCV, B12 and hemoglobin every 6–12 months if you remain on metformin.

Preventive Tips

  • Maintain a balanced diet with adequate B12 sources.
  • Limit alcohol intake and address any thyroid or liver issues.
  • Discuss with your doctor whether you need routine B12 supplementation when starting metformin.

Free, Online Symptom Check
Wondering whether your symptoms could be related to metformin or something else? Try a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance.

When to Speak to a Doctor
Even with high MCV and normal hemoglobin, always let your healthcare provider know about any new or concerning symptoms. If you experience anything potentially life-threatening or seriously disruptive—like severe neuropathy, sudden cognitive changes, or unexplained bruising—seek medical attention right away.

Bottom Line
Yes, long-term metformin use can raise your MCV without immediately lowering hemoglobin, most often through progressive vitamin B12 deficiency. Early detection allows you to correct B12 levels and prevent anemia or neurological complications. Keep an eye on your blood tests, discuss supplementation with your doctor, and use tools like the Ubie Symptom Checker for extra peace of mind.
Always speak to a doctor about any serious or life-threatening concerns.

(References)

  • * Kirkiz S, Yarali N, Arman Bilir O, Tunc B. Metformin-induced hemolytic anemia. Med Princ Pract. 2014;23(2):183-5. doi: 10.1159/000356149. Epub 2013 Nov 27. PMID: 24296614; PMCID: PMC5586851.

  • * Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S. Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis. Ann Intern Med. 2016 Jun 7;164(11):740-51. doi: 10.7326/M15-2650. Epub 2016 Apr 19. PMID: 27088241.

  • * Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T, Ellipse Trial Investigators. Liraglutide in Children and Adolescents with Type 2 Diabetes. N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28. PMID: 31034184.

  • * Yang W, Zhu D, Gan S, Dong X, Su J, Li W, Jiang H, Zhao W, Yao M, Song W, Lu Y, Zhang X, Li H, Wang G, Qiu W, Yuan G, Ma J, Li W, Li Z, Wang X, Zeng J, Yang Z, Liu J, Liang Y, Lu S, Zhang H, Liu H, Liu P, Fan K, Jiang X, Li Y, Su Q, Ning T, Tan H, An Z, Jiang Z, Liu L, Zhou Z, Zhang Q, Li X, Shan Z, Xue Y, Mao H, Shi L, Ye S, Zhang X, Sun J, Li P, Yang T, Li F, Lin J, Zhang Z, Zhao Y, Li R, Guo X, Yao Q, Lu W, Qu S, Li H, Tan L, Wang W, Yao Y, Chen D, Li Y, Gao J, Hu W, Fei X, Wu T, Dong S, Jin W, Li C, Zhao D, Feng B, Zhao Y, Zhang Y, Li X, Chen L. Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2022 May;28(5):974-981. doi: 10.1038/s41591-022-01803-5. Epub 2022 May 12. PMID: 35551292; PMCID: PMC9117147.

  • * Ochoa-Morales PD, González-Ortiz M, Martínez-Abundis E, Pérez-Rubio KG, Patiño-Laguna ADJ. Anti-hyperglycemic effects of propolis or metformin in type 2 diabetes mellitus. Int J Vitam Nutr Res. 2023 Dec;93(6):498-506. doi: 10.1024/0300-9831/a000760. Epub 2022 Aug 15. PMID: 35965421.

  • * GRADE Study Research Group, Nathan DM, Lachin JM, Balasubramanyam A, Burch HB, Buse JB, Butera NM, Cohen RM, Crandall JP, Kahn SE, Krause-Steinrauf H, Larkin ME, Rasouli N, Tiktin M, Wexler DJ, Younes N. Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes. N Engl J Med. 2022 Sep 22;387(12):1063-1074. doi: 10.1056/NEJMoa2200433. PMID: 36129996; PMCID: PMC9829320.

  • * Wu Z, Zhang B, Chen F, Xia R, Zhu D, Chen B, Lin A, Zheng C, Hou D, Li X, Zhang S, Chen Y, Hou K. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study. Front Cell Infect Microbiol. 2022;12:1089991. doi: 10.3389/fcimb.2022.1089991. Epub 2023 Jan 4. PMID: 36704100; PMCID: PMC9872724.

  • * Dickerman BA, García-Albéniz X, Logan RW, Denaxas S, Hernán MA. Evaluating Metformin Strategies for Cancer Prevention: A Target Trial Emulation Using Electronic Health Records. Epidemiology. 2023 Sep 1;34(5):690-699. doi: 10.1097/EDE.0000000000001626. Epub 2023 May 23. PMID: 37227368; PMCID: PMC10524586.

  • * Yakout IA, Gallab MM, Mohamed DA, Hamdar H, I Ibrahim S, Mohamed A, Abdelshafi A, Abd-ElGawad M. Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis. Semin Oncol. 2024 Oct-Dec;51(5-6):163-174. doi: 10.1053/j.seminoncol.2024.10.001. Epub 2024 Oct 29. PMID: 39547874.

  • * Qin M, Chao L, Liu S. Comparative efficacy and safety of sitagliptin or gliclazide combined with metformin in treatment-naive patients with type 2 diabetes: A single-center, prospective, randomized, controlled, noninferiority study with genetic polymorphism analysis. Medicine (Baltimore). 2025 Jan 10;104(2):e41061. doi: 10.1097/MD.0000000000041061. PMID: 39792745; PMCID: PMC11730665.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.